Literature DB >> 10491592

Fragmentation of an alkali metal-attached peptide probed by collision-induced dissociation fourier transform mass spectrometry and computational methodology.

M J Tomlinson1, J R Scott, C L Wilkins, J B Wright, W E White.   

Abstract

Collision-induced dissociation of metal-cationized N-CBZ-Gly-Pro-Gly-Pro-Ala was studied by Fourier transform mass spectrometry. Lithium-, sodium-, potassium- and rubidium-cationized peptide species were generated by matrix-assisted laser desorption/ionization (MALDI) using 2,5-dihydroxybenzoic acid as matrix, together with appropriate metal salts. The experimental mass spectrometric results were interpreted with the aid of Monte Carlo conformational searches using the Amber(*) force field, together with ab initio molecular orbital calculations with Gaussian-94 for the singly lithium- and potassium-cationized peptides. It is concluded that metal coordination plays a key role in guiding the gas-phase fragmentation of the cationized peptide. In contrast to lithium and sodium, potassium and rubidium apparently do not coordinate to the C-terminal carbonyl. When the peptide is cationized with the two smaller alkali metals, losses corresponding to alanine and CBZ are observed, while the coordination of potassium and rubidium results in only CBZ loss upon dissociation. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491592     DOI: 10.1002/(SICI)1096-9888(199909)34:9<958::AID-JMS858>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  2 in total

1.  Electron capture dissociation of peptides metalated with alkaline-earth metal ions.

Authors:  Y M Eva Fung; Haichuan Liu; T-W Dominic Chan
Journal:  J Am Soc Mass Spectrom       Date:  2006-04-17       Impact factor: 3.109

2.  Generation and manipulation of sodium cationized peptides in the gas phase.

Authors:  Kelly A Newton; Scott A McLuckey
Journal:  J Am Soc Mass Spectrom       Date:  2004-04       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.